T uberculosis (TB), caused by Mycobacterium tuberculosis, is the second greatest infectious cause of death worldwide after HIV, accounting for 1.3 million deaths in 2012 (1). The only available vaccine, Mycobacterium bovis bacillus Calmette-Guérin (BCG), protects infants from disseminated forms of TB but has insufficient and inconsistent efficacy in protecting adults from pulmonary TB (1, 2). A vaccine preventing active pulmonary TB, the contagious form of the disease, would greatly impact the epidemic (3), and a better understanding of vaccine-induced mechanisms of protection is essential in developing new surrogate endpoints (4).Both CD4 ϩ Th1 (gamma interferon-positive [IFN-␥ ϩ ]) cells and CD8 ϩ T cells are critical for protection against TB (5). Specifically, CD4ϩ IFN-␥ ϩ interleukin 2-positive (IL-2 ϩ ) tumor necrosis factor ␣-positive (TNF-␣ ϩ ) polyfunctional T cells have been proposed as a correlate of vaccine-induced protective immunity in murine infection models (6). In infants, BCG vaccination induced specific cytokine expression in CD4 ϩ and CD8 ϩ T cells (7-9), including IFN-␥ ϩ IL-2 ϩ TNF-␣ ϩ polyfunctional CD4 ϩ T cells (10). However, there was no relation between the presence of such cells and the development of TB during follow-up (11).In adults, BCG vaccination induced CD4 ϩ IFN-␥ ϩ responses (12-14) as well as IFN-␥-and TNF-␣-secreting CD8 ϩ T cells with cytotoxic activity (15). However, data on the induction of polyfunctional T cells by BCG vaccination in adults have been conflicting (16,17). In one report, the induction of polyfunctional CD4 ϩ T cells was similar in magnitude in BCG-vaccinated infants and adults; however, when induction was analyzed as the proportion of polyfunctional versus single-cytokine-producing T cells, the proportion of polyfunctional CD4 ϩ T cells was larger in children than in adults (16). Further, studies on latent (controlled) versus active TB in adults yielded variable results on changes in monoand triple-cytokine-producing T cell subsets (18,19), such that it was suggested that polyfunctional T cells are also present in active TB disease and that these cells are not a surrogate marker of protection against TB in humans (19,20).Another explanation for the inconsistent protection induced by BCG against TB in adults is the induction of regulatory T cells (Tregs) by mycobacteria, which can dampen proinflammatory responses (21). In that context, we reported that live BCG triggers the specific activation of CD8 ϩ (but not CD4 ϩ ) Tregs from peripheral blood mononuclear cells (PBMCs) of mycobacterial purified protein derivative (PPD)-responsive adults (22), while others found that BCG vaccination induced CD4 ϩ Tregs in newborns (23) and adults (24). Here, in a small, well-defined cohort of pre-